![]() |
市场调查报告书
商品编码
1884050
处方太阳眼镜市场规模、占有率、成长及全球产业分析:按类型、应用和地区划分的洞察与预测(2024-2032 年)Prescription Sunglasses Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
随着越来越多的消费者寻求兼具视力矫正和紫外线防护功能的眼镜,全球处方太阳眼镜市场持续扩张。根据最新的市场评估,该市场在 2024 年的价值为 66.7 亿美元,2025 年将成长至 69.5 亿美元,预计到 2032 年将达到 94.4 亿美元,预测期内复合年增长率 (CAGR) 为 4.5%。处方太阳眼镜已从单纯的视力辅助工具发展成为生活方式和时尚产品,成为屈光不正、数位眼睛疲劳和强光照射人群的必备之选。
2024 年,欧洲以 38.98% 的市占率引领全球市场。这得益于强大的眼镜文化、奢侈时尚品牌以及设计师处方太阳眼镜日益增长的受欢迎程度。义大利、德国和法国等主要製造商和分销商的存在进一步巩固了该地区的领先地位。
市场动态
市场驱动因素
眼部疾病的上升趋势
近视、老花眼和其他屈光不正的发病率不断上升是推动全球处方太阳眼镜需求的主要因素。根据国际近视研究所 (IMI) 预测,到 2025 年,全球 30% 的人口将患有近视,到 2050 年,这一比例将达到约 50%。这种日益严重的负担正在推动人们对矫正眼镜的需求,尤其是在户外强光环境下工作的人。
此外,各大公司正积极拓展中国、印度和巴西等新兴市场,这些市场屈光不正的人口基数正快速成长。这种策略转变正在增加产品供应,并支持强劲的市场成长。
市场限制因子
保险覆盖范围有限
在许多已开发国家和发展中国家,处方太阳眼镜不在保险覆盖范围内,这构成了购买障碍。例如,美国医疗保险(Medicare)不涵盖眼镜产品的费用,仅在白内障手术后少数情况下才会报销。同样,印度的保险公司也不报销眼镜或太阳眼镜的费用。这迫使用户自费,限制了眼镜的普及。
市场机会
近视盛行率上升与技术创新
由于近视盛行率上升、可支配所得增加以及眼镜零售网络不断扩张,新兴经济体蕴藏着巨大的成长机会。各公司正迅速从传统分销模式转向全通路模式,同时提供线上线下购买通路。 2024年7月,Lenskart投资2,000万美元用于全通路扩张,以加强处方太阳眼镜的分销,从而为产品渗透开闢新的机会。
人工智慧与镜片验配、虚拟试戴工具和精准光学测量技术的融合,正在推动眼镜产业的进一步成长,尤其是在数位化优先的市场。
市场挑战
产品成本高
由于定製镜片、优质材料和先进镀膜,处方太阳眼镜比普通眼镜价格更高。美国、欧洲和中国之间的关税和进口限制进一步推高了价格。此外,某些国家严格的进出口法规也为製造商设置了障碍,影响全球供应链和零售价格。
市场趋势
时尚与功能的融合
处方太阳眼镜正在演变为整合蓝牙、扩增实境功能、健身应用和免持通讯工具的智慧型穿戴装置。 2025年5月,Meta宣布在印度推出Ray-Ban Meta智慧眼镜,体现了科技与时尚的融合。
采用生物醋酸纤维、竹子和再生塑胶製成的可持续眼镜正受到千禧世代和Z世代消费者的广泛青睐,重塑着长期的市场趋势。
细分市场亮点
按镜框款式
2024年,矩形镜框凭藉着适应性和在各年龄层的普及度,占据市场主导地位。方形镜框则位居第二,主要得益于强劲的时尚潮流和流行文化的影响。
按镜片类型
2024年,非偏光镜片因其在阳光充足地区的受欢迎程度而占据最大市场占有率。同时,偏光镜片也因其出色的户外可视性而保持强劲增长。
按应用
近视镜镜片因其高普及率,在2024年占据市场主导地位。截至2025年1月,据报道,超过40%的美国成年人患有近视。
依通路划分
2024年,零售商店占据市场主导地位,这主要得益于收购,例如Fielmann AG在2024年收购了Shopko Optical。由于电子商务的快速发展,预计在线商店的增长率最高。
欧洲
2024年,欧洲以26亿美元的市场规模领先,这主要得益于强劲的时尚需求和大型光学设备分销商的存在。
北美
北美市场排名第二,这得益于较高的眼部健康意识和智慧眼镜的早期普及。 Warby Parker在2023年持续扩张其零售网络,进一步巩固了其市场渗透率。
亚太地区
由于中产阶级收入的成长和老花眼患者人数的增加,中国和印度等国家正经历着强劲的市场成长。 2021年,光是中国就有超过4亿人患有老花眼。
The global prescription sunglasses market continues to expand as consumers increasingly seek eyewear that combines both vision correction and UV protection. According to the latest market assessment, the market was valued at USD 6.67 billion in 2024, is expected to rise to USD 6.95 billion in 2025, and is projected to reach USD 9.44 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period. Prescription sunglasses have evolved from simple optical aids into lifestyle and fashion products, becoming essential for individuals dealing with refractive errors, digital eye strain, and intense sunlight exposure.
In 2024, Europe dominated the global market with a 38.98% share, supported by strong eyewear culture, premium fashion brands, and rising adoption of designer prescription sunglasses. The region's leadership is further amplified by the presence of major manufacturers and distributors across Italy, Germany, and France.
Market Dynamics
Market Drivers
Rising Prevalence of Ocular Disorders
The growing incidence of myopia, presbyopia, and other refractive disorders is a major factor driving global demand for prescription sunglasses. According to the International Myopia Institute (IMI), 30% of the global population was myopic in 2025, and by 2050, nearly 50% is expected to be affected. This escalating burden is increasing the need for corrective eyewear, especially for individuals exposed to bright outdoor environments.
Furthermore, major players are actively entering emerging markets such as China, India, and Brazil, where the population base with refractive errors is rapidly expanding. This strategic shift enhances product accessibility and supports strong market growth.
Market Restraints
Limited Reimbursement Policies
In several developed and developing countries, prescription sunglasses lack insurance coverage, limiting affordability. For instance, U.S. Medicare does not cover eyewear products except for limited cases following cataract surgery. Similarly, insurance providers in India exclude spectacle and sunglasses reimbursement. This forces users to bear out-of-pocket expenses, restricting wider adoption.
Market Opportunities
Growing Myopia Cases & Technological Advancements
Emerging economies present massive growth opportunities due to rising myopia cases, increasing disposable incomes, and expanding optical retail networks. Companies are rapidly shifting from conventional distribution to omnichannel models, providing both in-store and online accessibility. In July 2024, Lenskart invested USD 20 million into omnichannel expansion to enhance prescription sunglasses distribution, opening new opportunities for product penetration.
The integration of AI for lens fitting, virtual try-on tools, and precise optical measurements is further enabling growth, especially in digital-first markets.
Market Challenges
High Product Costs
Prescription sunglasses cost more than regular eyewear due to custom lenses, premium materials, and advanced coatings. Tariffs and import restrictions between the U.S., Europe, and China further elevate prices. Additionally, stricter import/export rules in certain nations pose barriers for manufacturers, impacting global supply chains and retail pricing.
Market Trends
Fashion Meets Function
Prescription sunglasses have evolved into smart wearable devices, integrating Bluetooth, AR features, fitness applications, and hands-free communication tools. In May 2025, Meta announced the introduction of Ray-Ban Meta smart glasses in India, showcasing the blend of technology and fashion.
Sustainable eyewear, made using bio-acetate, bamboo, and recycled plastics, is gaining significant traction among millennials and Gen Z consumers, reshaping long-term market trends.
Segmentation Highlights
By Frame Style
The rectangle frame segment dominated in 2024 due to its adaptability across age groups and rising availability. Square frames accounted for the second-largest share, supported by strong fashion trends and pop culture influence.
By Lens Type
Non-polarized lenses held the largest share in 2024 due to widespread adoption in high-sunlight regions. The polarized segment remains strong due to superior outdoor clarity.
By Application
Myopia led the market in 2024, backed by high prevalence rates. More than 40% of U.S. adults were reported to be nearsighted in January 2025.
By Distribution Channel
Retail stores dominated in 2024, supported by acquisitions such as Fielmann AG's 2024 acquisition of Shopko Optical. Online stores are expected to grow at the highest rate due to rapid e-commerce expansion.
Europe
Europe led the market with USD 2.60 billion in 2024, driven by strong fashion demand and the presence of large optical distributors.
North America
The market ranked second, supported by high awareness of ocular health and early adoption of smart eyewear. Warby Parker's continued retail expansion in 2023 strengthened market penetration.
Asia Pacific
Countries like China and India are experiencing strong market growth due to rising middle-class incomes and increasing prevalence of presbyopia-China alone had 400 million+ presbyopic individuals in 2021.
Conclusion
With market values rising from USD 6.67 billion in 2024 to USD 6.95 billion in 2025 and projected to reach USD 9.44 billion by 2032, the global prescription sunglasses market is on a steady growth path. Increasing vision disorders, technological advancements, premium eyewear trends, and expanding online distribution will continue to shape the industry over the coming decade.
Segmentation By Frame Style
By Lens Type
By Application
By Distribution Channel
By Region